2024
Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression
Swanberg K, Prinsen H, Averill C, Campos L, Kurada A, Krystal J, Petrakis I, Averill L, Rothman D, Abdallah C, Juchem C. Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression. NMR In Biomedicine 2024, 37: e5220. PMID: 39054694, DOI: 10.1002/nbm.5220.Peer-Reviewed Original ResearchPosttraumatic stress disorderMedial prefrontal cortexStress disorderPosttraumatic stress disorder patientsPosttraumatic stress disorder diagnosisChronic psychiatric conditionImpact of psychiatric comorbiditiesComorbid MDDPrefrontal cortexDepressive disorderTraumatic stressorsPsychiatric conditionsMDDPsychiatric comorbiditiesNeurotransmitter abnormalitiesConcentrations of glutamateMetabolite abnormalitiesHealthy controlsDisordersPattern of abnormalitiesParticipantsGlutamateIn vivo protonMetabolic abnormalitiesDepression
2020
1772-P: Reversibility of Altered Brain Glucose Kinetics in T2DM
RANGEL E, GUNAWAN F, JIANG L, SAVOYE M, DAI F, ROTHMAN D, MASON G, HWANG J. 1772-P: Reversibility of Altered Brain Glucose Kinetics in T2DM. Diabetes 2020, 69 DOI: 10.2337/db20-1772-p.Peer-Reviewed Original ResearchBrain glucose levelsPoor glycemic controlGlycemic controlGlucose levelsCentral nervous system complicationsNervous system complicationsBrain glucose transportPlasma glucose levelsContinuous glucose monitoringUncontrolled T2DMT2DM subjectsSystem complicationsBMI changeHyperglycemic clampHealthy controlsDiabetes regimenPost interventionHierarchical linear regression modelsGlucose time coursesMagnetic resonance spectroscopyHbA1cGlucose kineticsGlucose monitoringNational InstituteT2DM